Paolo Vigneri

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Diabetes and cancer.

Laura Sciacca, P. Vigneri, F. Frasca, 2009, Endocrine-related cancer.

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

P. Vigneri, Jean Y. J. Wang, Paolo Vigneri, 2001, Nature Medicine.

Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway.

Fiorenza Gianì, P. Vigneri, F. Frasca, 2013, The Journal of clinical endocrinology and metabolism.